Literature DB >> 3827115

Results following reduction mammaplasty as evaluated by the patients.

M Pers, I M Nielsen, N Gerner.   

Abstract

Reduction mammaplasty was performed on 365 patients using the technique of Pers and Bretteville-Jensen. Two to 13 years after the operation, the patients were asked to complete questionnaires; the answers were analyzed and compared with answers from a smaller group of patients who had undergone surgery with McKissock's technique. Primary complications to the procedure were few, and it is remarkable that total necrosis of the nipple was absent in the series. More than 80% of the patients had their general expectations fulfilled, but one third in both groups found the resulting scars unacceptable. The character of the scars seems to be more important than the location. Primary complications were more frequent in overweight patients, and preoperative weight regulation is recommended. An improvement in the character of scars after reduction mammaplasty would be beneficial, and detailed preoperative information is essential if postoperative disappointment is to be avoided.

Entities:  

Mesh:

Year:  1986        PMID: 3827115     DOI: 10.1097/00000637-198612000-00003

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  3 in total

1.  Subjective comparison of six different reduction mammoplasty procedures.

Authors:  L Hang-Fu
Journal:  Aesthetic Plast Surg       Date:  1991       Impact factor: 2.326

2.  Reduction mammaplasty for the teenage patient: a critical analysis.

Authors:  G R Evans; J J Ryan
Journal:  Aesthetic Plast Surg       Date:  1994       Impact factor: 2.326

Review 3.  The impact of breast reduction surgery on breastfeeding: Systematic review of observational studies.

Authors:  Roni Y Kraut; Erin Brown; Christina Korownyk; Lauren S Katz; Ben Vandermeer; Oksana Babenko; M Shirley Gross; Sandy Campbell; G Michael Allan
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.